Clinical appointment card issued to a patient treated for Chronic Myeloid Leukaemia, 1998-2001

Patient appointment card given to Doreen Eggleton (married name Short) recording medical appointments during treatment for Chronic Myeloid Leukaemia (CML), issued by West Middlesex Hospital listing haematology dept., 1998-2001. Doreen went on to be part of the first UK clinical trial for the targeted therapy Glivec (imatinib).

This hospital appointment card records the medical appointments Doreen Eggleton had whilst treated for a blood cancer called Chronic Myeloid Leukaemia (CML) between 1998-2001. Doreen went on to become one of the patients participating in the first UK clinical trial of the targeted therapy Glivec (imatinib), a drug that was shown to improve the survival of patients with CML like Doreen.